MedPath

Quinidine Gluconate

QUINIDINE GLUCONATE EXTENDED-RELEASE TABLETS USP

Approved
Approval ID

5023f053-fcc4-4c2c-aa59-9ec198ad185e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 1, 2018

Manufacturers
FDA

Sun Pharmaceutical Industries, Inc.

DUNS: 146974886

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Quinidine Gluconate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code53489-141
Application NumberANDA089338
Product Classification
M
Marketing Category
C73584
G
Generic Name
Quinidine Gluconate
Product Specifications
Route of AdministrationORAL
Effective DateFebruary 1, 2018
FDA Product Classification

INGREDIENTS (1)

Quinidine GluconateActive
Quantity: 324 mg in 1 1
Code: R6875N380F
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Quinidine Gluconate - FDA Drug Approval Details